1-7 of 7
J J Mulé
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Identification of human cancers deficient in antigen processing.

N P Restifo, F Esquivel, Y Kawakami, J W Yewdell, J J Mulé, S A Rosenberg, J R Bennink
Journal: Journal of Experimental Medicine
J Exp Med (1993) 177 (2): 265–272.
https://doi.org/10.1084/jem.177.2.265
Published: 01 February 1993
View articletitled, Identification of human cancers deficient in antigen processing.
Open the PDF for Identification of human cancers deficient in antigen processing. in another window
Journal Articles

A nonimmunogenic sarcoma transduced with the cDNA for interferon gamma elicits CD8+ T cells against the wild-type tumor: correlation with antigen presentation capability.

N P Restifo, P J Spiess, S E Karp, J J Mulé, S A Rosenberg
Journal: Journal of Experimental Medicine
J Exp Med (1992) 175 (6): 1423–1431.
https://doi.org/10.1084/jem.175.6.1423
Published: 01 June 1992
View articletitled, A nonimmunogenic sarcoma transduced with the cDNA for interferon gamma elicits CD8+ T cells against the wild-type tumor: correlation with antigen presentation capability.
Open the PDF for A nonimmunogenic sarcoma transduced with the cDNA for interferon gamma elicits CD8+ T cells against the wild-type tumor: correlation with antigen presentation capability. in another window
Journal Articles

Interleukin 7 generates antitumor cytotoxic T lymphocytes against murine sarcomas with efficacy in cellular adoptive immunotherapy.

D L Jicha, J J Mulé, S A Rosenberg
Journal: Journal of Experimental Medicine
J Exp Med (1991) 174 (6): 1511–1515.
https://doi.org/10.1084/jem.174.6.1511
Published: 01 December 1991
View articletitled, Interleukin 7 generates antitumor cytotoxic T lymphocytes against murine sarcomas with efficacy in cellular adoptive immunotherapy.
Open the PDF for Interleukin 7 generates antitumor cytotoxic T lymphocytes against murine sarcomas with efficacy in cellular adoptive immunotherapy. in another window
Journal Articles

Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes.

R J Barth, Jr, J J Mulé, P J Spiess, S A Rosenberg
Journal: Journal of Experimental Medicine
J Exp Med (1991) 173 (3): 647–658.
https://doi.org/10.1084/jem.173.3.647
Published: 01 March 1991
View articletitled, Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes.
Open the PDF for Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes. in another window
Journal Articles

Antitumor activity of recombinant interleukin 6 in mice.

J J Mulé, J K McIntosh, D M Jablons, S A Rosenberg
Journal: Journal of Experimental Medicine
J Exp Med (1990) 171 (3): 629–636.
https://doi.org/10.1084/jem.171.3.629
Published: 01 March 1990
View articletitled, Antitumor activity of recombinant interleukin 6 in mice.
Open the PDF for Antitumor activity of recombinant interleukin 6 in mice. in another window
Journal Articles

Interleukin 4 (B cell stimulatory factor 1) can mediate the induction of lymphokine-activated killer cell activity directed against fresh tumor cells.

J J Mulé, C A Smith, S A Rosenberg
Journal: Journal of Experimental Medicine
J Exp Med (1987) 166 (3): 792–797.
https://doi.org/10.1084/jem.166.3.792
Published: 01 September 1987
View articletitled, Interleukin 4 (B cell stimulatory factor 1) can mediate the induction of lymphokine-activated killer cell activity directed against fresh tumor cells.
Open the PDF for Interleukin 4 (B cell stimulatory factor 1) can mediate the induction of lymphokine-activated killer cell activity directed against fresh tumor cells. in another window
Journal Articles

Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.

S A Rosenberg, J J Mulé, P J Spiess, C M Reichert, S L Schwarz
Journal: Journal of Experimental Medicine
J Exp Med (1985) 161 (5): 1169–1188.
https://doi.org/10.1084/jem.161.5.1169
Published: 01 May 1985
View articletitled, Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.
Open the PDF for Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2. in another window